Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) — Stock Score Summary

Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) has a MoatMap StockRank of 67/100 based on Quality (54/100), Value (53/100), and Momentum (43/100) factor scores. The current signal is BUY. Guangzhou Kingmed is a clinical laboratory service provider. It does not possess the high-moat, proprietary-platform characteristics of a validated CDMO and is subject to domestic healthcare pricing pressures.

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides independent clinical laboratory (ICL) testing services to hospitals and medical institutions. The company is the largest third-party medical diagnostic service provider in China, with a nationwide network of over 30 laboratories covering over 90% of the population. It is the clear market leader in China's ICL industry, benefiting from massive scale economies and a comprehensive test menu.

Key Financial Metrics

Price$3.55
Market Cap$1.8B
P/E (Forward)16.75
Price/Book1.76
Return on Equity-1.4%
Return on Invested Capital-2.2%
Debt/Equity13.23
Gross Margin35.1%
Operating Margin5.4%
Revenue Growth-7.9%
Dividend Yield7.3%
Free Cash Flow$18M

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates in the Diagnostics & Research industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Guangzhou Kingmed Diagnostics Group Co., Ltd.’s (603882.SS) StockRank?
MoatMap’s StockRank for Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) is 67/100, with a Buy signal. It is a composite of Quality (54), Value (53), and Momentum (43) factor ranks across MoatMap’s 19,000+ stock universe.
Does Guangzhou Kingmed Diagnostics Group Co., Ltd. have an economic moat?
Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Guangzhou Kingmed Diagnostics Group Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) is Buy, based on a StockRank of 67/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Guangzhou Kingmed Diagnostics Group Co., Ltd. in?
Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).
Browse all ranked stocks603882.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock